Geoffrey C. Dunbar

2009

In 2009, Geoffrey C. Dunbar earned a total compensation of $569.2K as Senior Vice President, Clinical Development and Regulatory Affairs and Chief Medical Officer at Catalyst Biosciences, a 59% increase compared to previous year.

Compensation breakdown

Bonus$83,708
Non-Equity Incentive Plan$89,821
Option Awards$88,835
Salary$292,102
Other$14,700
Total$569,166

Dunbar received $292.1K in salary, accounting for 51% of the total pay in 2009.

Dunbar also received $83.7K in bonus, $89.8K in non-equity incentive plan, $88.8K in option awards and $14.7K in other compensation.

Rankings

In 2009, Geoffrey C. Dunbar's compensation ranked 6,395th out of 9,885 executives tracked by ExecPay. In other words, Dunbar earned more than 35.3% of executives.

ClassificationRankingPercentile
All
6,395
out of 9,885
35th
Division
Manufacturing
2,331
out of 3,690
37th
Major group
Chemicals And Allied Products
506
out of 866
42nd
Industry group
Drugs
341
out of 638
47th
Industry
Pharmaceutical Preparations
242
out of 446
46th
Source: SEC filing on April 21, 2011.

Dunbar's colleagues

We found four more compensation records of executives who worked with Geoffrey C. Dunbar at Catalyst Biosciences in 2009.

2009

J deBethizy

Catalyst Biosciences

Chief Executive Officer

2009

Jeffrey Brennan

Catalyst Biosciences

Senior Vice President, Business and Commercial Development and Chief Business Officer

2009

Alan Musso

Catalyst Biosciences

Chief Financial Officer

2009

Peter Zorn

Catalyst Biosciences

General Counsel

You may also like